SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19 1, 2, 3,
4, 5. The dynamics of antibody-secreting plasmablasts and germinal centre B cells …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …

Long-lived bone marrow plasma cells (BMPCs) are a persistent and essential source of
protective antibodies 1, 2, 3, 4, 5, 6, 7. Individuals who have recovered from COVID-19 have a …

Background: Patients with chronic inflammatory disease (CID) treated with immunosuppressive
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…

Germinal centres (GC) are lymphoid structures in which B cells acquire affinity-enhancing
somatic hypermutations (SHM), with surviving clones differentiating into memory B cells (MBCs…

SARS-CoV-2 mRNA vaccines induce robust anti-spike (S) antibody and CD4 + T cell
responses. It is not yet clear whether vaccine-induced follicular helper CD4 + T (T FH ) cell …

Although activated murine NK cells can use the granule exocytosis pathway to kill target cells
immediately upon recognition, resting murine NK cells are minimally cytotoxic for unknown …

We pursued a study of immune responses in coronavirus disease 2019 (COVID-19) and
influenza patients. Compared to patients with influenza, patients with COVID-19 exhibited …

Influenza viruses remain a major public health threat. Seasonal influenza vaccination in
humans primarily stimulates pre-existing memory B cells, which differentiate into a transient …

This article has been corrected. The original version (PDF) is appended to this article as a
Supplement . Background: Nonnucleoside reverse transcriptase inhibitor–based antiretroviral …